Sex |
Sex |
|
Male |
Male |
16152 (58%) |
Female |
Female |
11701 (42%) |
Other |
Other |
9 (0%) |
Days from symptom onset to hospitalization |
Days from symptom onset to
hospitalization |
5 [2, 7] |
Age |
|
57 [41, 73] |
|
0-64 |
16927 (60.7%) |
|
65- |
10938 (39.3%) |
Ethnicity |
|
|
Japanese |
Japanese |
26407 (95.8%) |
Other ethnicity |
Other ethnicity |
1156 (4.2%) |
Smoking history |
|
|
Former or current smoker
Never
Unknown
|
Former or current smoker
Never
Unknown
|
10246 (36.9%)
|
|
|
12771 (46.0%) |
|
|
4771 (17.2%) |
Drinking alcohol |
|
|
Daily (3 cans per day)
Occasional
None
Unknown
|
Daily (3 cans per day)
Occasional
None
Unknown
|
2087 (7.6%)
|
|
|
9301 (34.1%) |
|
|
9179 (33.6%) |
|
|
6738 (24.7%) |
BMI |
BMI |
23.5 [20.9, 26.5] |
Contact history within 14 days before onset |
Contact history within 14
days before onset |
|
Travel to COVID-19 countries |
Travel to COVID-19 countries |
432
(1.6%) |
Contact with COVID-19 patients |
Contact with COVID-19 patients |
13934
(50.3%) |
NEWS score |
|
|
0–4
5–6
7-
Unknown
|
0–4
5–6
7-
Unknown
|
21568 (77.4%)
|
|
|
2320 (8.3%) |
|
|
1759 (6.3%) |
|
|
2218 (8%) |
No oxygen administration during admission |
No oxygen administration
during admission |
17530 (62.9%) |
Oxygen administration during admission |
Oxygen administration during
admission |
8844 (31.7%) |
Ventilator use during admission |
Ventilator use during admission |
1483(5.3%) |
Comorbidities |
Comorbidities |
|
No comorbidity |
No comorbidity |
13659 (49.1%) |
Any comorbidity |
Any comorbidity |
14206 (50.9%) |
Cerebrovascular Disease |
Cerebrovascular Disease |
1738
(6.2%) |
Bronchial Asthma |
Bronchial Asthma |
1479 (5.3%) |
COPD/Chronic Lung Disease |
COPD/Chronic Lung Disease |
1050
(3.8%) |
Liver Dysfunction |
Liver Dysfunction |
688 (2.5%) |
Hypertension |
Hypertension |
8239 (29.6%) |
Hyperlipidemia |
Hyperlipidemia |
4001 (14.4%) |
Diabetes Mellitus |
Diabetes Mellitus |
4693 (16.8%) |
Obesity diagnosed by physicians |
Obesity diagnosed by physicians |
1686
(6.1%) |
Moderate to Severe Renal Dysfunction/Hemodialysis |
Moderate to Severe
Renal Dysfunction/Hemodialysis |
471 (1.7%) |
Solid Tumor/Metastatic Solid Tumor |
Solid Tumor/Metastatic Solid Tumor |
1062 (3.8%) |
Leukemia/Lymphoma |
Leukemia/Lymphoma |
171 (0.6%) |
Collagen Disease |
Collagen Disease |
356 (1.3%) |
HIV/AIDS |
HIV/AIDS |
55 (0.2%) |
Outcome |
Outcome |
|
Discharge |
Discharge |
20872 (74.9%) |
Transfer to a different hospital |
Transfer to a different hospital |
3326 (11.9%) |
Transfer to non-medical facility |
Transfer to non-medical facility |
1331 (4.8%) |
Transfer to long-term care facility |
Transfer to long-term care
facility |
1043 (3.7%) |
Death |
Death |
1285 (4.6%) |